In Committee
To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
Sponsor
Rep. Tonko, Paul [D-NY-20]Democratic · New YorkCommittee
Judiciary CommitteeLast action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 20, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · Nov 20, 2026
Introduced Nov 20, 2026
Members signed on after the sponsor
Offered against this measure
No roll calls stored